NCT06311474 2026-03-18
RAINBOW
University of California, Los Angeles
Phase NA Completed
Clinical Trials
33 trialsNCT05104983 2026-01-22
TSC-STEPS
Children's Hospital Medical Center, Cincinnati
Phase 2 Recruiting
NCT05467397 2026-01-21
Feasibility of [11C]Acetate-PET in LAM and TSC
Brigham and Women's Hospital
Phase 1/2 Active not recruiting
NCT06879665 2025-09-22
TANDem-2
Vrije Universiteit Brussel
Phase NA Enrolling by invitation
NCT04698538 2024-10-30
TRAIN
University of California, Los Angeles
Phase NA Completed
NCT02849457 2024-08-19
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
University of Alabama at Birmingham
Phase 2 Completed
NCT04595513 2024-05-16
STOP2
Children's Hospital Medical Center, Cincinnati
Phase 1/2 Completed
NCT05867576 2024-02-14
ACT in TSC
University Hospitals Bristol and Weston NHS Foundation Trust
Phase NA Unknown
NCT04987463 2024-02-08
ViRap
Children's Memorial Health Institute, Poland
Phase 2/3 Recruiting
NCT04344626 2023-10-10
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery
University of California, Los Angeles
Phase NA Withdrawn
NCT05534672 2023-08-08
RaRE-TS
Children's Memorial Health Institute, Poland
Phase 3 Recruiting
NCT02451696 2021-09-01
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
NYU Langone Health
Phase 2 Completed
NCT02860494 2021-05-03
EVEROST
Hospices Civils de Lyon
Phase 2/3 Withdrawn
NCT01929642 2021-03-29
RAPT
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase 2 Completed
NCT03422367 2020-11-06
JETS
University of California, Los Angeles
Phase NA Unknown
NCT01526356 2020-10-26
Treatment
The University of Texas Health Science Center, Houston
Phase 2 Completed
NCT02201212 2020-09-16
Everolimus for Cancer With TSC1 or TSC2 Mutation
Dana-Farber Cancer Institute
Phase 2 Completed
NCT02061397 2020-08-25
SOS
University of Pennsylvania
Phase 1/2 Completed
NCT03356769 2020-06-09
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03326765 2018-10-17
Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)
Universitair Ziekenhuis Brussel
Phase NA Unknown
NCT02687633 2018-05-02
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
University of California, Los Angeles
Phase NA Completed
NCT03254680 2018-04-30
Turmeric as Treatment in Epilepsy
NYU Langone Health
Phase NA Withdrawn
NCT01289912 2018-01-25
TSC
Boston Children's Hospital
Phase 2 Completed
NCT02104011 2018-01-23
STBETA
University Hospital, Bordeaux
Phase 2 Completed
NCT03140449 2017-05-04
Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis
National Taiwan University Hospital
Phase 3 Completed
NCT01070316 2017-03-13
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Children's Hospital Medical Center, Cincinnati
Phase 1/2 Completed
NCT00989742 2015-12-02
Doxycycline In Lymphangioleiomyomatosis (LAM)
University of Nottingham
Phase 4 Completed
NCT01730209 2015-05-05
RAPIT
Erasmus Medical Center
Phase 2/3 Unknown
NCT02098759 2014-04-04
EPISTOP
Children's Memorial Health Institute, Poland
Phase NA Unknown
NCT00792766 2013-09-18
Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
Children's Hospital Medical Center, Cincinnati
Phase 1/2 Completed
NCT01031901 2012-02-27
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
The University of Texas Health Science Center, Houston
Phase 1 Completed
NCT00490789 2008-04-30
TESSTAL
Cardiff University
Phase 2 Unknown
NCT00457808 2007-04-09
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Children's Hospital Medical Center, Cincinnati
Phase 2 Completed